Day: October 23, 2025

                                                        Charenton-le-Pont, 23 October 2025 Q3 2025 revenues Sales down 10.5%1 vs. Q3 2024Significant decline in the France cluster due to difficult annual commercial negotiations with Off-Trade chainsSlight decline in international sales amid a global market slowdownNine-month 2025 revenues down 9.2%1 at €127.5mFrance: continued sharp decline in sales, down 19.3% for the first nine months against a backdrop of challenging annual commercial negotiations with the Off-Trade and continuing decline in the spirits market. Q3 sales down 23.4% in line with the Q2 trend.The William Peel brand was penalised by delisting among certain Off-Trade distributors and the ensuing loss of market share; The Marie Brizard brand posted sales growth driven by innovations launched in 2024; The Sobieski...

  Press Release   The project launch event, held at the Vertolaye site, brought together State officials, elected representatives, and several project partners to accelerate pharmaceutical innovation in Europe Paris – October 23, 2025 – EUROAPI officially launched its innovation programs today as part of the Health IPCEI (Important Project of Common European Interest), a European initiative aimed at strengthening pharmaceutical sovereignty. This project, called “Med4Cure,” is supported by the European Commission. The inaugural event took place at the EUROAPI Vertolaye (Puy-de-Dôme) site in the presence of State representatives, local elected officials, and public and private partners involved in the project. The project led by EUROAPI initially involves start-ups such as Abolis (expert in biotechnology), Alysophil (specialized in...

  PRESS RELEASENantes, October, 23rd, 2025   3rd quarter and 9-month sales 2025 highlightsTransformation yielding results in a volatile market environment, Net sales Q3 2025 +5,9% LfL  Growth on Retail and International Retail delivered +8% LfL with Southern Europe confirming its dynamism  New concept for shopping center continues to deliver double digit growth, new re-opening in Italy Stabilization of Online and France France sales returned to slight growth (+2% LfL) in a challenging environment marked by historically high savings rates, low consumer confidence and store disruptions linked to strikes Online sales also stabilized, growing by +1%: MdM sales remained broadly flat and Marketplace regained momentum Inspire Everyday Initiatives supporting Q3 resultsEarlier launch of seasonal products thanks to enhanced S&OP...

Revenue at September 30, 2025 Return to growth in Q3 20259-month revenue: €586.5 million, down 2.8% at CER1 and on a like-for-like basis2, largely due to the fall in activity in France An increase in Q3 of 2.6% at CER and on a like-for-like basis, underpinned by the acceleration of EluciremTM sales and good momentum on Lipiodol®Confirmation of all financial targets for 2025 Villepinte, October 23, 2025, 5.45 p.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is publishing its revenue for the first nine months of 2025. At September 30, 2025, Group sales totaled €586.5 million, representing a decrease of 5.5%. At constant exchange rates (CER)1, sales fell by 3.1%, incorporating a negative foreign exchange effect of €14.6 million, mainly due to the depreciation of the currencies...

          COMPANGNIE DE L’ODET      Financial information for Q3 2025 23 October 2025  Revenue (at constant scope and exchange rates): -24% in third-quarter 2025 -10% in the first nine months of 2025 Revenue for Q3 2025  At constant scope and exchange rates, Group revenue for third-quarter 2025 totaled 630 million euros, down 24%:Bolloré Energy: 530 million euros, -25%, impacted by the general fall in petroleum product prices, as well as a decrease in volumes sold over the quarter; Industry: 73 million euros, -21%, mainly due to the decline in BlueBus business activity, which in 2024 benefited from the upturn in sales of 12-meter buses, and despite growth in the Films business.On a reported basis, revenue was down 22% compared with third-quarter 2024, taking into account +26 million euros in changes in scope, linked...

     PRESS RELEASEQuarterly financial information as of September 30, 2025IFRS – Regulated information – Not audited Cegedim: like-for-like revenue growth of 2.1% over 9 months is on targetRevenue of €153.7 million in Q3 2025, up 0.5%Q3 growth engines: cloud, HR, digitalization and health & provident insurance solutions Cumulative 9M 2025 revenue of €476.1 millionBoulogne-Billancourt, France, October 23, 2025, after the market close Revenue  Third quarter Change Q3 2025 / 2024in millions of euros 2025 2024 Reported Life for like(1)(2)Software & Services 71.5 75.6 (5.4)% +0.0%Flow 25.3 23.7 +6.8% +7.0%Data & Marketing 27.7 28.2 (1.7)% (2.3)%BPO 19.3 21.6 (10.7)% (10.7)%Cloud & Support 9.9 7.7 +27.6% +27.6%Cegedim 153.7 156.8 (2.0)% +0.5%  First 9 months Change...

HIAB CORPORATION, STOCK EXCHANGE RELEASE, 23 OCTOBER 2025 AT 6:45 PM (EEST) Hiab’s financial information in 2026 Hiab Corporation will disclose the following financial information in 2026:Financial Statements review 2025 on Thursday, 12 February 2026 Interim report January–March 2026, on Friday, 24 April 2026 Half year financial report January–June 2026, on Wednesday, 22 July 2026 Interim report January–September 2026, on Friday, 23 October 2026Hiab’s Financial Statements 2025 and Annual Report 2025 will be available at www.hiabgroup.com on week 8. The Annual General Meeting of Hiab Corporation will be held on Tuesday, 24 March 2026. Shareholders, who request a certain issue belonging to the General Meeting to be included in the agenda of the Meeting, must notify the Board of Directors in writing no later than 16...

MCLEAN, Va., Oct. 23, 2025 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading cybersecurity solutions provider, announced today that the previously announced one-for-thirty reverse stock split of the Company’s shares of common stock, par value $0.0001 per share (the “Reverse Stock Split”) will take effect, and the Company’s shares of common stock will begin trading on a split-adjusted basis on The Nasdaq Global Market, as of the opening of trading on October 27, 2025, under the existing trading symbol “CYCU”. The CUSIP number of 95758L305 will be assigned to the Company’s shares of common stock when the Reverse Stock Split becomes effective.   On October 10, 2025, the Company’s board of directors determined to effect the Reverse Stock Split. On August 28, 2025, holders of a majority of the...

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) — Fusemachines Inc. (NASDAQ: FUSE) (“Fusemachines” or the “Company”), a global leader in enterprise AI solutions, today announced the commencement of trading of the Company’s common stock on the Nasdaq Stock Market under the symbols “FUSE”. We believe this milestone marks a new chapter in Fusemachines’ mission to democratize AI for all, expanding access to advanced artificial intelligence technologies, education, and innovation across global markets. The company’s public listing positions it to capture the rapidly expanding global demand for scalable AI solutions. “From starting with a small, mission-driven team to becoming a publicly listed company on Nasdaq, this milestone reflects our unwavering commitment to innovation and execution,” said Dr. Sameer Maskey, CEO and Founder of Fusemachines....